Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-03-23
1998-12-29
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530385, A61K 3714, C07K 302, C07K 322
Patent
active
058542094
ABSTRACT:
The present invention relates to a method of therapeutically, or prophylactically, treating a vertebrate to increase tissue oxygenation, or maintain issue oxygenation, in tissue of a vertebrate wherein the tissue has a reduced red blood cell flow, and wherein the vertebrate has a normovolemic blood volume and at least a normal systemic vascular resistance. The method comprises introducing into the circulatory system of the vertebrate at least one dose of hemoglobin.
REFERENCES:
patent: 4001401 (1977-01-01), Bonsen et al.
patent: 4704402 (1987-11-01), Abraham et al.
patent: 4988515 (1991-01-01), Buckberg
patent: 5084558 (1992-01-01), Rausch et al.
patent: 5296465 (1994-03-01), Rausch et al.
patent: 5296466 (1994-03-01), Kilbourn et al.
patent: 5334706 (1994-08-01), Przybelski
Teisher et al. J. Oxygenation of tumors by a hemoglobin solution. Cancer Research and Clinical Oncology, 120 (1-2), 1993.
Paradis et al. Selective aortic perfusion and oxygenetion: An effective adjunct to external chest compression-based cardiopulmonary resuscitation. J. American College of Cardiology, 23 (2), 497-495, 1994.
Krieter et al. Effects of stroma-free polymerized bovine hemoglobin solution on oxygen transport, global and regional blood flow in a canine model of stepwise hemodilution. Anesth. Analg., 78(2) S226, 1994.
Waschke et al. Amer. J. Physiol., 265, H1243-H1248, Jun. 1993.
Biro, G. P., et al., "Early Deleterious Hemorheologic Changes Following Acute Experimental Coronary Occlusion and Salutary Antihyperviscosity Effect of Hemodilution with Stroma-Free Hemoglobin," American Heart Journal, 103(5): 870-878 (1982).
Biro, G. P., and Beresford-Kroeger, D., "The Effect of Hemodilution with Stroma-Free Hemoglobin and Dextran on Collateral Perfusion of Ischemic Myocardium in the Dog," American Heart Journal, 99(1): 64-75 (1980).
Cole, D. J., et al., "Focal Cerebral Ischemia in Rats: Effect of Hypervolemic Hemodilution with Diaspirin Cross-Linked Hemoglobin versus Albumin on Brian Injury and Edema," Anesthesiology, 78(2): 335-342 (1993).
Cole, D. J., et al., "Focal Cerebral Ischemia in Rats: Effect of Hemodilution with .alpha.-.alpha. Cross-Linked Hemoglobin on CBF," J. Cereb. Blood Flow Metab., 12(6): 971-976 (1992).
Cole, D. J., et al., "Effects of Viscosity and Oxygen Content on Cerebral Blood Flow in Ischemic and Normal Rat Brain," Journal of Neurological Sciences, 124: 15-20 (1994).
Feola, M., et al., "Clinical Trial of a Hemogolbin Based Blood Substitute in Patients with Sickle Cell Anemia," SURGERY, Gynecology & Obstetrics, 174: 379-386 (1992).
Feola, M., et al., "Improved Oxygenation of Ischemic Myocardium by Hemodilution with Stroma-Free Hemoglobin Solution," CHEST, 75(3): 369-375 (1979).
Hauser, C. J., and Shoemaker, W. C., "Hemoglobin solution in the Treatment of Hemorrhagic Shock," Critical Care Medicine, 10(4): 283-287 (1982).
Homer, L. D., et al., "Oxygen Gradients Between Red Blood Cells in the Microcirculation," Hypoxia Between Red Cells, Academic Press, Inc. 308-323 (1981).
Leone, B. J., and Spahn, D. R., "Anemia, Hemodilution, and Oxygen Delivery," Anesth. Analg. 75: 651-653 (1992).
Sarelius, I. H., "Cell and Oxygen Flow in Arterioles Controlling Capillary Perfusion," Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1682-H1687 (1993).
Standl, T., et al., "Hemodynamics and Oxygen Transport During Complete Isovolemic Hemodilution With a New Ultrapurified Polymerized Bovine Hemoglobin Solution in a Dog Model." Paper presented at the Annual Meeting of the American Society of Anesthesiologists, Washington (1993) and at the Central European Congress of Anaesthesiology, Dresden (1993).
Tsai, A. G., and Intaglietta, M., "Local Tissue Oxygenation During Constant Red Blood Cell Flux: A Discrete Source Anaylsis of Velocity and Hematocrit Changes," Microvascular Research 37: 308-322 (1989).
Wei, E. P., et al., "Effect of Local Change in O.sub.2 Saturation of Hemoglobin on Cerebral Vasodilation from Hypoxia and Hypotension," Am. J. Physiol., 265 (Heart Circ. Physiol. 34): H1439-H1443 (1993).
Chu, D., et al., Abstract 80.13, "The Effect of Hemodilution with a Purified Monomer or Purified Bovine Hemoglobin on Infarct Size in Focal Ischemia in Rabbits," Society for Neuroscience Abstracts, 20:180 (1994), presented at the 24th Annual Meeting Society of Neuroscience, Miami Beach, FL (Nov. 13-18, 1994).
Jacobs, Jr. Edward E.
Rausch Carl W.
Biopure Corporation
Borin Michael
Tsang Cecilia J.
LandOfFree
Method for oxygenating tissue having reduced red blood cell flow does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for oxygenating tissue having reduced red blood cell flow, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for oxygenating tissue having reduced red blood cell flow will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1424856